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Abstract
Background:  Neocarzinostatin is a potent antitumor drug consisting of an enediyne
chromophore and a protein carrier.
Methods:  We characterized an intermediate in the equilibrium unfolding pathway of
aponeocarzinostatin, using a variety of biophysical techniques including 1-anilino-8-napthalene
sulfonate binding studies, size-exclusion fast protein liquid chromatography, intrinsic tryptophan
fluorescence, circular dichroism, and 1H-15N heteronuclear single quantum coherence
spectroscopy.
Results: The partially unfolded protein is in molten globule-like state, in which ~60% and ~20%
tertiary and secondary structure is disrupted respectively. Despite lacking a fully coordinated
tertiary structure for assembling a functional binding cleft, the protein in molten globule-like state
is still able to fully protect the labile chromophore. Titration of chromophore leads the partially
denatured apoprotein to fold into its native state.
Conclusion: These findings bring insight into conserving mechanism of neocarzinostatin under
harsh environment, where even the partially denatured apoprotein exhibits protective effect,
confirming the superiority of the drug carrier.
Background
Neocarzinostatin (NCS) is the most studied member
within the family of natural enediyne-based chromopro-
teins with potent anti-tumor activity [1,2]. Holoneocarzi-
nostatin (holoNCS) drug consists of a biologically active
chromophore (NCS-Chr) that is non-covalently bound to
a carrier apoprotein (apoNCS). NCS-Chr is very labile and
can be inactivated quickly when it is not associated with
apoNCS [1,3,4]. To carry out the protection role, a regular
drug carrier protein must fold properly to form a well-
defined specific binding cleft before it can accommodate
the ligand molecule. Here we report an interesting obser-
vation that apoNCS in its partially unfolded intermediate
state is able to efficiently bind and protect the labile NCS-
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Chr. Elucidation of the protein folding with respect to
chromophore protection could serve as a starting point
for rational drug carrier design strategies.
ApoNCS is an all -sheet protein (~11 kDa) consisting of
an antiparallel -barrel and a -sheet domain (Fig. 1, NCS
model in an aqueous environment at pH 7 [5]). Folding
and unfolding pathways of this small all -sheet protein
have been an interesting topic recently studied by various
methods [6-11]. Results from some studies show that the
folding/unfolding of apoNCS may not follow a simple
two-state model, instead, stable folding intermediates
may be involved in the transition pathways [9-11]. None-
theless, detailed characterization of stable apoNCS fold-
ing/unfolding intermediates has not been reported.
Structural characterization of intermediates that populate
in the folding/unfolding process is crucial to understand
the protein folding mechanism. Equilibrium and kinetic
intermediates have been identified in the unfolding/
refolding reactions of several proteins [12-15]. The best
studied intermediate is the molten globule (MG) state
[16,17]. The MG states are believed to be general folding
intermediates because they populate both in the equilib-
rium and kinetic folding/unfolding pathways [16,17]. In
the present study, we identified and characterized a stable
intermediate in the guanidine hydrochloride (GdnHCl)-
induced equilibrium unfolding pathway of apoNCS.
Intermediate accumulates maximally in 1.2 M GdnHCl
under acidic condition and has structural properties
resembling that of a MG-like state. To gain insights into
the biological role of apoNCS as a drug carrier, the inter-




NCS powder consisting apoNCS and NCS-Chr in a 1:1
molar ratio was a gift from Kayaku Co., Ltd., Itabashi-Ku,
Tokyo, Japan. Extracted NCS-Chr was obtained after
repeated methanol extractions of lyophilized NCS stock
(0.5 mM, as determined by 340 = 10,800 M-1 cm-1) in 20
mM sodium citrate (pH 4), following the previously
described method [18]. Extracted NCS-Chr was stored at -
80°C in amber glass vials. Integrity and concentration of
NCS-Chr were examined by UV spectroscopy and HPLC
analysis. Labeled 15NH4Cl and D2O were purchased from
Cambridge Isotope Laboratories (Andover, MA, USA). All
other chemicals used were of high quality analytical
grade. All experiments were performed in 10 mM phos-
phate buffer (pH 3) at 25°C.
Expression and purification of apoNCS
Recombinant apoNCS was overexpressed and purified by
the procedure as described [19]. Homogeneity of the pro-
tein was examined by UV, HPLC and SDS-PAGE. Protein
yield was about 2 mg/L. Molecular mass of the purified
protein was verified using ESI-Mass analysis.
Preparation of isotope-enriched apoNCS
Uniform  15N labeling was achieved by the established
procedure [19]. E. coli BL21 Codon Plus strain (Strata-
gene, La Jolla, CA, USA) carrying the apoNCS gene was
cultured in M9 minimal medium containing 15NH4Cl
supplemented with vitamin B1. Final yield of the 15N-
labeled protein was about half of the corresponding unla-
beled protein expressed in LB medium.
Steady-State fluorescence measurements
Fluorescence spectra were collected using a Hitachi F-
4500 spectrofluorimeter at a resolution of 2.5 or 10 nm.
For GdnHCl-induced unfolding study, excitation wave-
length was set at 280 nm. Intrinsic fluorescence measure-
ments were made at 25°C. Binding affinity of 1-anilino-8-
napthalene sulfonate (ANS) to apoNCS at various concen-
trations of GdnHCl was monitored in a wavelength range
of 375 to 625 nm using an excitation wavelength at 355
nm. Excitation and emission bandwidths were set at 5
nm. Concentration of ANS and protein was 100 M and
Three-dimensional model of holoNCS in an aqueous envi- ronment at pH 7 Figure 1
Three-dimensional model of holoNCS in an aqueous 
environment at pH 7. The model was modified [5] from 
Brookhaven pdb.1nco.ent file. Chromophore is shown as a 
ball-and-stick representation (magenta). The all -sheet 
holoNCS (cyan) consists of an antiparallel -barrel and a 
small double-stranded -sheet domain.Journal of Biomedical Science 2009, 16:48 http://www.jbiomedsci.com/content/16/1/48
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10 M respectively. All samples were prepared in 10 mM
phosphate buffer at pH 3.
Circular dichroism (CD) spectroscopy
All CD measurements are carried out on a Jasco J-715
spectropolarimeter (Tokyo, Japan) equipped with a circu-
lating water bath (Neslab, model RTE-140) (Portsmouth,
NH, USA). Measurements were made using a 0.1 cm path-
length water-jacketed quartz cell. Each spectrum repre-
sents an average of 30 scans with a scan speed of 50 nm/
min. Concentration of the protein used was 15 M. Back-
ground corrections were made in all spectra. Bandwidth
was set to 1 nm and all spectra were acquired at 25°C.
Size-exclusion chromatography (SEC)
Gel-filtration experiments were carried out at 25°C on a
superdex-100 column using a Pharmacia AKTA FPLC
chromatographic device (GE Healthcare Bio-Sciences AB,
Uppsala, Sweden). Column was equilibrated with 2 bed
volumes of 10 mM phosphate buffer (pH 3) containing
appropriate concentrations of GdnHCl at a flow rate of 1
ml/min. Concentration of protein used for each analysis
was approximately 250 g/ml (dissolved in appropriate
concentrations of GdnHCl). Protein elution was moni-
tored by UV absorbance at 280 nm.
Thermal denaturation experiments
Thermal stability of apoNCS in 10 mM phosphate buffer
(pH 3) in the presence or absence of 1.2 M GdnHCl was
monitored by far-UV CD at 224 nm. Changes in ellipticity
with temperature were followed from 5–91°C at an incre-
ment of 3°C. Experiments were performed using a water-
jacketed cell connected to a thermal circulator equipped
with a microprocessor and temperature sensor. Protein
sample (25 M) was allowed to equilibrate for 10 minutes
at each temperature before data acquisition.
NMR experiments
The NMR experiments were carried out on a Bruker DMX
600 MHz NMR spectrometer (Rheinstetten, Germany) at
25°C. A 5 mm inverse probe with a self-shielded z-gradi-
ent was used to obtain all gradient-enhanced 1H-15N
HSQC spectra [20,21]. 15N decoupling during acquisi-
tions was achieved using the GARP sequence [22]. Total of
2048 complex data points were collected in the 1H-
dimension of the 1H-15N HSQC experiments. In the indi-
rect 15N-dimension spectra, 512 complex data points were
collected. The HSQC spectra were recorded by 32 scans at
all concentrations of GdnHCl. 15N chemical shifts were
referenced using consensus ratio of 0.0101329118. All
spectra were processed on a Silicon Graphics workstation
using XWINNMR and Sparky softwares.
Binding experiments
Binding experiments were performed in 10 mM phos-
phate buffer (pH 3) by incubating 20 M apoNCS (in the
presence or absence of 1.2 M GdnHCl) with NCS-Chr at
1:1 molar ratio for 30 minutes at 25°C. The final metha-
nol content introduced from NCS-Chr stock was kept
minimal to about 4% (v/v). Analyses of the protein-
bound NCS-Chr after binding experiments were per-
formed through a Waters -Bondapak reverse phase C18
column by a Waters Millennium HPLC equipped with a
model 600E solvent delivery system, a 996 photodiode
array detector and either a Waters 474 or a Jasco FP-1520
fluorescence detector following previously described
method [23].
Results
GdnHCl-induced unfolding of apoNCS does not follow a 
two-state model
GdnHCl-induced equilibrium unfolding of apoNCS at
pH 3 was monitored by changes in intrinsic tryptophan
fluorescence and far-UV CD at 224 nm. Circular dichr-
oism spectrum of the all -sheet apoNCS protein is some-
what atypical [24] with a large positive maximum at 224
nm and small negative minimum centered at 212 nm [7].
Fluorescence and far-UV CD spectral probes have been
shown to reliably report the gross tertiary and secondary
structural changes that possibly occur during the unfold-
ing of apoNCS [11]. Fig. 2 shows that GdnHCl-induced
equilibrium unfolding of apoNCS under acidic condition
(pH 3) monitored by changes in intrinsic tryptophan flu-
orescence is completely reversible. The fluorescence
unfolding profile of apoNCS shows that the protein starts
to unfold in 0.6 M GdnHCl. Unfolding of the protein is
completed beyond 3 M GdnHCl (Fig. 2). Cm (concentra-
tion of GdnHCl at which 50% of the protein molecules
are in denatured state) and 'm' (measure of cooperativity
of unfolding process) are 1.1 ± 0.1 M and 7.3 ± 0.7 kJ mol-
1 M-1 respectively. Change in free energy of unfolding
obtained in the absence of the denaturant [G (H2O)] is
estimated to be 8.5 ± 0.1 kJ mol-1. Interestingly, the Gdn-
HCl-induced unfolding curve obtained by measuring
ellipticity changes at 224 nm is not superimposable with
that obtained by monitoring the changes in intrinsic tryp-
tophan fluorescence. These results possibly suggest that
the unfolding of apoNCS may not follow a two-state
model, and may involve accumulation of stable interme-
diate states (Fig. 2). Cm, 'm' and [G (H2O)] estimated
from the unfolding profile obtained using far-UV CD are
1.8 ± 0.1 M, 4.4 ± 0.2 kJ mol-1 M-1and 8.6 ± 0.5 kJ mol-1
respectively.
A stable equilibrium unfolding intermediate of apoNCS
Size-exclusion chromatography (SEC) is a useful tech-
nique to acquire information on integral changes of
molecular dimensions under the effect of the denaturantJournal of Biomedical Science 2009, 16:48 http://www.jbiomedsci.com/content/16/1/48
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[25,26]. This technique has been successfully used to
identify and obtain hydrodynamic data on stable interme-
diates in the folding/unfolding pathway of proteins [25].
ApoNCS in 10 mM phosphate buffer (pH 3) in the
absence of GdnHCl elutes as a single peak with an elution
volume of ~129 ml (Fig. 3). On increasing the concentra-
tion of GdnHCl from 0 to 0.2 M, the elution volume of
the protein peak sharply decreases to about ~111 mL.
Interestingly, elution volume of the protein does not sig-
nificantly change when the GdnHCl concentration is
increased from 0.4 M to 1.2 M (Fig. 3). A clear plateau can
be observed in the plot of elution volume versus concen-
tration of GdnHCl suggesting the accumulation of a stable
equilibrium intermediate in this range of denaturant con-
centration. Beyond 1.2 M GdnHCl, elution volume of the
protein changes drastically and profile eventually reaches
a plateau at 2 M GdnHCl. It should be mentioned that
apoNCS elutes as a single peak at various concentrations
of GdnHCl indicating that the protein exists as a single
population at all concentrations of the denaturant (Fig. 3,
inset). Uversky [26], using size-exclusion chromatography
to study the denaturant-induced equilibrium unfolding
profile of proteins, showed that proteins such as -lacta-
mase, bovine carbonic anhydrase and -lactoglobulin,
which denature through a MG-like intermediate, also
elute as single peaks at all concentrations of the denatu-
rant [26]. The results of the SEC-FPLC experiment clearly
show that the GdnHCl-induced unfolding of apoNCS
proceeds through the accumulation of a stable intermedi-
ate at around 1.2 M GdnHCl at pH 3 (Fig. 3). At pH above
3 no stable intermediate was observed. The first phase of
apoNCS unfolding between 0–1.2 M GdnHCl appears to
represent an equilibrium transition between the native
and the intermediate state.
Partially unfolded apoNCS intermediate resembles MG-
like state
Under optimal conditions (pH 3, 1.2 M GdnHCl) where
the stable unfolding intermediate of apoNCS accumu-
lates, considerable percentage (about 80%) of the second-
ary structure remains undisrupted, whereas 60% of the
tertiary structure is disrupted (Fig. 2). This is a good indi-
cation that the stable intermediate could be in MG-like
state. ANS is a fluorescent dye that binds to the hydropho-
bic regions of proteins [27] and this fluorescent probe has
been immensely useful in the identification of equilib-
rium intermediates such as MG states. MG intermediates
usually display significant exposure of hydrophobic cores
to the solvent. Therefore, ANS binds strongly to MG states
and fluoresces intensely [28,29]. The dye generally exhib-
its weak binding affinity to the native and denatured pro-
teins [28]. The binding affinity of apoNCS to ANS at
various concentrations of GdnHCl was monitored by
changes in the emission intensity at 475 nm (Fig. 4). The
ANS emission intensity upon binding to apoNCS in 1.2 M
GdnHCl is significantly higher than that observed with
the protein in its folded state (Fig. 4). Further increase in
the concentration of GdnHCl (beyond 1.2 M) results not
only in the progressive decrease in the emission intensity
but also in a continuous red shift in the emission maxima.
The protein in its unfolded conformations, at and beyond
3 M GdnHCl, exhibits weak binding to ANS (Fig. 4). Thus,
the results of ANS binding and SEC-FPLC experiments,
analyzed in conjunction, clearly suggest that a MG-like
intermediate accumulates maximally in 1.2 M GdnHCl.
Thermal stability of MG-like intermediate of apoNCS
It is important to understand the stability of the equilib-
rium unfolding intermediate states in relation to the
folded state of the protein. In this context, we carried out
thermal denaturation of apoNCS in the presence and
absence of 1.2 M GdnHCl at pH 3 (Fig. 5). Thermal
unfolding monitored by ellipticity changes at 224 nm
shows that apoNCS at pH 3 unfolds to denatured state at
temperatures beyond 62°C (Fig. 5). Apparent Tm (temper-
ature at which 50% of the protein molecules exist in the
denatured state) of the unfolding reaction is about 52 ±
1°C. In marked contrast, the MG-like state of the protein
at the same pH level in 1.2 M GdnHCl unfolds almost
completely beyond 50°C (Fig. 5). Tm of the MG-like state
to denatured state of apoNCS is 35 ± 1°C. These results
Fraction of unfolded apoNCS at various concentrations of  GdnHCl Figure 2
Fraction of unfolded apoNCS at various concentra-
tions of GdnHCl. The GdnHCl-induced unfolding at 25°C 
was monitored by changes in fluorescence emission at 340 
nm (excited at 280 nm) (open circle) and ellipiticity at 224 
nm (black circle). The concentration of apoNCS used in the 
fluorescence and far-UV CD experiments was 5 and 15 M, 
respectively. Samples were prepared in 10 mM phosphate 
buffer at pH 3.Journal of Biomedical Science 2009, 16:48 http://www.jbiomedsci.com/content/16/1/48
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suggest that the protein in the MG-like state is signifi-
cantly less stable than the folded state. It appears that
some of the interactions stabilizing the compactly folded
conformation are disrupted in MG-like state.
NMR studies on structural changes in MG-like state of 
apoNCS
Two-dimensional  1H-15N heteronuclear single quantum
coherence (HSQC) NMR spectroscopy serves as a finger-
print of the conformational state of a protein. It provides
residue level information on the structural changes that
possibly occur during unfolding/folding processes. We
synthesized and purified 15N-labeled apoNCS and moni-
tored GdnHCl-induced unfolding by 1H-15N chemical
shift perturbation. Heteronuclear correlation experiments
have been shown to be very sensitive because of high mag-
netization transfer between directly bonded nuclei. Fig.
6A shows that 2D 1H-15N HSQC spectrum of apoNCS at
pH 3 in the absence of GdnHCl is well-dispersed, which is
a characteristic feature of a folded protein. Striking differ-
ences can be discerned in the HSQC spectra obtained in
the absence and presence of 1.2 M GdnHCl. Many cross
peaks in HSQC spectrum of the protein in 1.2 M GdnHCl
are broadened, suggesting the overall flexibility of resi-
dues in the intermediate state (in 1.2 M GdnHCl) is signif-
icantly higher than that in the folded state (Fig. 6A).
Though it is not easy to identify residues in the partially
denatured state, we attempted to make an assignment by
recording a series of HSQC NMR spectrum of apoNCS at
pH 5 to 3 with 0.5 decrement of pH level. 1H and 15N
GdnHCl-induced unfolding of apoNCS demonstrated by SEC analyses Figure 3
GdnHCl-induced unfolding of apoNCS demonstrated by SEC analyses. The changes in elution volume of apoNCS at 
pH 3 were measured at various concentration of GdnHCl. Transition from native (N) to intermediate (I) state occurs in the 
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backbone chemical shifts of native apoNCS at pH 5 were
assigned based on the reported values (105 of 113 resi-
dues of apoNCS were reported) [30]. Once the cross peaks
of apoNCS spectrum obtained at pH 3 were assigned, they
were compared with those recorded at pH 3 in the pres-
ence of GdnHCl. By stepwise comparison, we identified
70 residues in the spectrum of MG-like state of apoNCS.
The weighted average (of 15N and 1H) chemical shift per-
turbation (() = [(H)2 + 0.2 (15N)2)]1/2) of residues in
MG-like state of apoNCS is shown in Fig. 6B, in which the
unassigned residues (residues 1–3, 5, 8, 9, 15, 19, 24, 28,
31, 38–44, 46, 48, 49, 53, 54, 56, 59, 62, 66, 75, 78, 79,
81, 82, 87, 89, 92, 93, 97, 99, 100, 103, 105, 106, 112) as
well as the residues with perturbation below 0.1 ppm (the
threshold of the average minimal perturbation) were
eliminated. The result clearly shows that residues at N-
and C-termini of the protein are significantly perturbed in
the MG-like state (Fig. 6B). Most of the residues that show
significant chemical shift changes or peak broadening
appear to be those not involved in the secondary structure
formation (Fig. 6A and 6B). HSQC spectra of apoNCS
acquired beyond 4 M GdnHCl show significant decrease
in chemical shift dispersion in 1H dimension indicating
complete unfolding of the protein (Fig. 6A). The results of
the NMR experiments suggest that although the interac-
tions at loop regions and both N- and the C-termini of the
protein are perturbed, the secondary structural elements
in the protein appear to be mostly unaffected in the equi-
librium intermediate in 1.2 M GdnHCl.
ApoNCS in partially unfolded MG-like state fully protects 
labile NCS-Chr
NCS manifests its antineoplastic effects through damage
to the cellular genome [1]. The very potent cytotoxic activ-
ities come from the enediyne warhead NCS-Chr, which is
very labile by itself [3]. At pH 8, the life time of free NCS-
Chr in an aqueous environment is only few seconds [4].
Binding with apoNCS increases the life time of NCS-Chr
to several thousand folds [4]. Thus, the degree of protec-
tion against spontaneous NCS-Chr degradation can serve
as a good probe to assess the binding affinity towards
NCS-Chr [4,31]. To examine whether apoNCS in MG-like
state binds to NCS-Chr, an aliquot of NCS-Chr was incu-
bated with 1:1 molar ratio of apoNCS at pH 3 and 25°C
for 30 min in the presence and absence of 1.2 M GdnHCl.
The remaining amount of intact NCS-Chr was analyzed by
HPLC following the previously established method [23].
The results clearly show that NCS-Chr was fully protected
in the presence of either folded or MG-like state of
apoNCS (Table 1). Evidently, the MG-like state of
apoNCS in 1.2 M GdnHCl retains its full ability to bind to
its enediyne chromophore.
Binding of ANS to apoNCS at various concentrations of  GdnHCl Figure 4
Binding of ANS to apoNCS at various concentrations 
of GdnHCl. Fluorescent emission intensity of ANS (100 
M) in the presence of apoNCS (10 M) was followed at 
25°C in different concentration of GdnHCl using an excita-
tion wavelength at 355 nm. Samples were prepared in 10 mM 
phosphate buffer at pH 3. Inset shows emission spectra of 
ANS with apoNCS in native (N, in 0 M GdnHCl), intermedi-
ate (I, in 1.2 M GdnHCl) and denatured (D, in 4 M GdnHCl) 
state.
Thermal unfolding of apoNCS at the intermediate state Figure 5
Thermal unfolding of apoNCS at the intermediate 
state. Heat-induced unfolding of apoNCS was monitored by 
changes in ellipticity at 224 nm in the absence (black circle) 
and presence (open circle) of 1.2 M GdnHCl. ApoNCS sam-
ples (25 M) were prepared in 10 mM phosphate buffer at 
pH 3.Journal of Biomedical Science 2009, 16:48 http://www.jbiomedsci.com/content/16/1/48
Page 7 of 11
(page number not for citation purposes)
NMR analysis of apoNCS in various concentrations of GdnHCl Figure 6
NMR analysis of apoNCS in various concentrations of GdnHCl. (A) 1H-15N HSQC spectra of apoNCS obtained at 
25°C in 0, 1.2, and 4 M GdnHCl. Residues which show maximum perturbation in the intermediate state in 1.2 M GdnHCl are 
boxed. (B) The weighted average (of 15N and 1H) chemical shift perturbation of residues in 1.2 M GdnHCl. ApoNCS samples 
(720 M) were prepared in 10 mM phosphate buffer (pH 3) in 90% H2O and 10% D2O. The -strands in the protein are shown 
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MG-like state of apoNCS resumes its folded state after 
binding to NCS-Chr
Titration of NCS-Chr into native state apoNCS can pro-
duce drastic changes in the near-UV CD spectrum [19,32].
Binding of 1:1 molar ratio of NCS-Chr with native
apoNCS produces a prominent negative ellipticity peak
minimum at 255 nm, which is a characteristic feature of
the native form of holoNCS. Interestingly, titration of 1:1
molar ratio of NCS-Chr into MG-like state of apoNCS in
1.2 M GdnHCl at pH 3 produces identical CD spectrum to
that of the native holoNCS (Fig. 7). The results unambig-
uously suggest that NCS-Chr not only can bind to
apoNCS in partially unfolded MG-like state but also help
the protein fold back into its native state. Without NCS-
Chr, the near-UV CD spectroscopy of the MG-like state of
apoNCS shows that 60% of the tertiary structure is dis-
rupted (Fig. 7, inset). The observation is consistent with
that from intrinsic tryptophan fluorescence study (Fig. 2).
Discussion
Understanding the mechanism by which a protein folds
from denatured state into its unique native three-dimen-
sional structure is an important problem in molecular
biology [33,34]. ApoNCS, being a model for small all -
sheet proteins, has been extensively investigated for its
folding/unfolding pathways [6-11]. Formation of inter-
mediate state has been suggested when apoNCS is treated
with 45% trifluoroethanol at pH 5 [11]. Under aqueous
condition, we demonstrated that the thermal unfolding of
apoNCS at pH 7 follows a two-state mechanism [7]. On
the contrary, small-angle neutron scattering studies on
apoNCS at pH 7 reveal that there could be several discrete
intermediate species at equilibrium populated in the
unfolding pathways [9,10]. The distribution of those sub-
states shows various degrees of residual structures and
appears to be temperature or solvent dependent. The
major species present during the transition could be con-
siderably unstructured, which may make the thermal
unfolding transition look like a two-state transition [9].
This accounts for the failure of identifying a well-defined
intermediate state in the unfolding pathway of apoNCS at
pH 7 [10]. In the present study, we identified and charac-
terized a stable MG-like state in the GdnHCl-induced
unfolding pathway of apoNCS only at a rather acidic pH
(pH 3). At pH 5, where apoNCS is stable at room temper-
ature [7], we have shown that apoNCS is highly resistant
against denaturants [35]. The transitions of apoNCS
induced by GdnHCl can not be complete even at the high-
est concentration of the denaturant. Here we also screened
GdnHCl-induced unfolding pathways of aqueous
apoNCS at 25°C over a pH range of 3 to 9 (data not
shown). We could not observe any stable intermediates
except at pH 3. Conceivably, the chances of characterizing
a stable intermediate are limited by conditions. We wish
the present characterization of a MG-like state intermedi-
ate would provide some inputs for further understanding
of the complex folding/unfolding mechanism of apoNCS.
Potent anti-neoplastic activity of NCS comes from its
NCS-Chr, and apoNCS serves its functional role as a car-
rier and protector [1,3,4]. Without apoNCS, NCS-Chr is
very labile and can be inactivated quickly by bases, light,
heat, and chemicals such as cellular thiols [1,3,4]. When
NCS-Chr and apoNCS are biosynthesized from specific
gene clusters that produce NCS, the peptide chain of
apoNCS needs to fold properly and efficiently to form
specific binding cleft for accommodation of the chromo-
phore. Statistical studies have suggested that proteins with
more complex topologies such as -sheets usually fold
more slowly than proteins with -helices [36]. ApoNCS
being an all -sheet protein, its topology is not favorable
for fast folding. Although the role of ligand in protein
folding is not well understood, there are studies showing
that binding of a ligand prior to protein folding can signif-
icantly accelerate the formation of functional protein
[37]. Our in vitro experimental data show that apoNCS in
its partially unfolded MG-like state resumes its native state
after binding with NCS-Chr (Fig. 7). In our opinion, it
Table 1: Protection of NCS-Chr against degradation by binding with MG-like state of apoNCS
Sample contents Remaining % of NCS-Chra
NCS-Chr 0%
NCS-Chr + 1.2 M GdnHCl 13 ± 4%b
holoNCS (NCS-Chr + 1:1 folded state of apoNCS) 100 ± 4%
NCS-Chr + 1:1 MG-like state of apoNCS (in 1.2 M GdnHCl) 101 ± 4%c
a Samples containing 20 M NCS-Chr were incubated with folded or MG-like state of apoNCS in 10 mM phosphate aqueous buffer at pH 3 and 
25°C for 30 min. Remaining amount of intact NCS-Chr was analyzed by HPLC.
b Most NCS-Chr was degraded in acidic aqueous condition in the presence of 1.2 M GdnHCl. The small remaining amount of the NCS-Chr 
exhibited additional forms. About 35 ± 10% of the remaining NCS-Chr was converted into chlorohydrin form of the chromophore. It is known that 
the chlorohydrin derivative of NCS-Chr can be obtained by treatment of HCl [2]. Presumably, excess amount of GdnHCl triggers the conversion 
process.
c No chlorohydrin conversion could be found in the remaining NCS-Chr in the presence of MG-like state of apoNCS. Presumably, binding of 
apoNCS prevents the chromophore conversion reaction triggered by excess amount of GdnHCl.Journal of Biomedical Science 2009, 16:48 http://www.jbiomedsci.com/content/16/1/48
Page 9 of 11
(page number not for citation purposes)
may not be far-fetched to assume that in cellular environ-
ment, NCS-Chr binds apoNCS and effectively converts it
into a functional protein for its own protection.
Recently, we have demonstrated apoNCS as a superior
drug carrier, as its conformation is stable at wide pH range
between 4–10 [7] and is highly resistant against organic
solvents and chemical denaturants [35]. Here we further
confirmed the superiority of apoNCS, as it exhibits high
capability in binding and protecting the labile enediyne
chromophore even under harsh acidic environment,
where apoNCS conformation becomes intrinsically unsta-
ble and disrupted. How is NCS-Chr protected by the
apoNCS unfolding intermediate is an interesting ques-
tion. Based on the structural information obtained from
NMR results (Fig. 6), residues T6, S10, S11, S14, and G16
at N-terminus, N60 and D58 at the loop region between
the -strand V (residues 53–57) and VI (residues 62–66),
and S98, G104, G107, N113, and S111 at C-terminus are
highly perturbed in the MG-like state of apoNCS. On the
other hand, majority of the residues involved in the sec-
ondary structural interactions do not show appreciable
chemical shift changes or broadening. Residues at the bot-
tom of the chromophore binding cleft such as V34, G35,
Q36, L45, G96, V95, and V108 show only small perturba-
tion. In addition, the chemical shift of F52 and the
disulfide bond C37-C47, both locate right below the nine-
membered enediyne ring, are not significantly affected
( of C47 is 0.094537 ppm, smaller than the 0.1 ppm
threshold). It appears that many residues involved in the
chromophore binding are not highly perturbed in the
transition to the MG-like state. This probably accounts, at
least in part, for the retaining ability of the MG-like state
of apoNCS in binding and protecting the labile enediyne
chromophore.
Besides being potent carrier of the natural ligand enediyne
chromophore, apoNCS has also been demonstrated as a
CD spectra of apo- and holoNCS in MG-like and native state Figure 7
CD spectra of apo- and holoNCS in MG-like and native state. CD spectra of the natural holoNCS (dotted line) in 10 
mM phosphate buffer (pH 3) and the constituted holoNCS of NCS-Chr and MG-like state of apoNCS (full line) in 1.2 M Gdn-
HCl (pH 3). MG-like state of apoNCS for constitution was prepared by incubating 15 M apoNCS with 1.2 M GdnHCl in 10 
mM phosphate (pH 3) at 25°C for 30 min. Constitution was performed prior to CD measurement by adding 1:1 molar ratio of 
methanol extracted NCS-Chr into aqueous solution containing MG-like state of apoNCS. Final methanol content was kept 
minimal to about 4% (v/v).Inset: Near-UV CD spectrum of apoNCS in MG-like state (full line) (in the presence of 1.2 M Gdn-
HCl (pH 3)) and in folded state (dotted line) (in the absence of GdnHCl in 10 mM phosphate buffer (pH 3)). All CD spectra 
were recorded in mean residue ellipticity at 25°C.Journal of Biomedical Science 2009, 16:48 http://www.jbiomedsci.com/content/16/1/48
Page 10 of 11
(page number not for citation purposes)
carrier of small synthetic molecules like EtBr [38], naph-
thoate ester derivatives [30,39,40] and flavone-based lig-
and [41]. Interestingly, apoNCS is useful in improving the
stability of potent DNA alkylating agents, nitrogen mus-
tards [40]. Furthermore, in vitro 'evolution' studies
revealed that apoNCS could be engineered into a com-
mon drug delivery vehicle [42]. Drug packaging for drug
delivery systems has drawn extensive interests lately in the
field of medicinal chemistry. Our study brings insight into
the conserving mechanism of naturally occurring NCS
and consequently merits apoNCS as a naturally built
superior drug carrier for rational drug design strategies.
Conclusion
We identified and characterized the stable MG-like state
accumulated in the equilibrium early unfolding pathway
of apoNCS in the presence of 1.2 M GdnHCl under acidic
(pH 3) and aqueous conditions. The apoNCS intermedi-
ate retains about 80% and 40% of the secondary and ter-
tiary structure, respectively. With the impaired binding
cleft, the MG-like state of apoNCS still exhibits full capa-
bility of protecting the labile enediyne chromophore. The
results demonstrate apoNCS as the natural built-in supe-
rior drug carrier. Further CD analyses showed that NCS-
Chr not only binds to the MG-like state of apoNCS but
also converts the partially unfolded protein to its func-
tional native state of holoNCS for self protection.
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